Literature DB >> 1676933

Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?

E Melamed1, A Achiron, A Shapira, S Davidovicz.   

Abstract

Drug-induced parkinsonism is usually reversible, except in a small percentage of elderly patients. We describe two relatively young patients, who developed drug-induced parkinsonism during chronic treatment with neuroleptics for a psychotic disorder. Parkinsonism persisted, and markedly and progressively deteriorated after discontinuation of neuroleptic drugs. One patient had tremor as the most prominent sign and the other had mainly an akinetic-rigid syndrome. Neither had ever developed tardive dyskinesia. Both responded to levodopa therapy. Persistent drug-induced parkinsonism in our, and other reported on, elderly patients may be due to unmasking of preexisting subclinical idiopathic Parkinson's disease by neuroleptics. Theoretically, these drugs may precipitate degeneration of vulnerable, nigrostriatal neurons by generating cytotoxic free radicals or by attrition, due to accelerated neuronal firing rates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676933     DOI: 10.1097/00002826-199106000-00013

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  7 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

2.  Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.

Authors:  Aasef G Shaikh
Journal:  Neurol Sci       Date:  2017-02-22       Impact factor: 3.307

3.  Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.

Authors:  V Bocola; G Fabbrini; A Sollecito; C Paladini; N Martucci
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

Review 4.  Treatment of psychosis in Parkinson's disease: safety considerations.

Authors:  Hubert H Fernandez; Martha E Trieschmann; Joseph H Friedman
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  Drug-induced parkinsonism in the aged. Recognition and prevention.

Authors:  O S Gershanik
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

6.  Parkinsonism and tremor disorders. A clinical approach.

Authors:  Hani Ts Benamer
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

7.  Use of antipsychotics and long-term risk of parkinsonism.

Authors:  Angelo d'Errico; Elena Strippoli; Rosario Vasta; Gianluigi Ferrante; Stefania Spila Alegiani; Fulvio Ricceri
Journal:  Neurol Sci       Date:  2021-10-15       Impact factor: 3.830

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.